The U.S. Food and Drug Administration has warned eight companies to stop marketing unproven over-the-counter chelation”therapies” as treatments for autism, cardiovascular diseases, Alzheimer’s and other conditions. The products’ distributors have claimed they cure a range of diseases by removing heavy metals from the body.
“These products are dangerously misleading because they are targeted to patients with serious conditions and limited treatment options,” said Deborah Autor, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research. “The FDA must take a firm stand against companies who prey on the vulnerability of patients seeking hope and relief.”
A series of articles in the Chicago Tribune found widespread evidence that parents of children with autism were using chelation on their children, even though it has not been found to be safe and effective.